MedTrace Logo

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)

NCT04431687 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2020-11-16

No results posted yet for this study

Summary

A Clinical trial to investigate the pharmacokinetic drug interaction and safety of CKD-501, D759 and D150

Conditions

Interventions

DRUG

CKD 501

QD, PO

DRUG

D759, D150

QD, PO

DRUG

CKD-501, D759, D150

QD, PO

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Anhye Kim, Ph.D · CHA University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-15
Primary Completion
2020-07-24
Completion
2020-10-26

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04431687 on ClinicalTrials.gov